The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarclays Regulatory News (BARC)

Share Price Information for Barclays (BARC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 213.95
Bid: 213.90
Ask: 214.00
Change: 0.70 (0.33%)
Spread: 0.10 (0.047%)
Open: 213.30
High: 215.15
Low: 212.60
Prev. Close: 213.25
BARC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - TAKEDA PHARMACEUTICAL CO LTD - AMENDMENT

10 Dec 2018 08:16

FORM 8.3 Amendment to Purchase

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser: Barclays PLC.
(b) Owner or controller of interest and short
positions disclosed, if different from 1(a):
(c) Name of offeror/offeree in relation to whose

TAKEDA PHARMACEUTICAL CO LTD

relevant securities this form relates:
(d) If an exempt fund manager connected with an
offeror/offeree, state this and specify identity of
offeror/offeree:
(e) Date position held/dealing undertaken: 30 November 2018
(f) In addition to the company in 1(c) above, is the discloser making YES:
disclosures in respect of any other party to the offer? SHIRE PLC

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security: Ordinary NPV
Interests Short Positions
Number (%) Number (%)
(1) Relevant securities owned
and/or controlled: 11,520,549 1.47% 13,589,516 1.71%
(2) Cash-settled derivatives:
12,725,186 1.60% 10,375,600 1.31%
(3) Stock-settled derivatives (including options)
and agreements to purchase/sell: 10,521,600 1.32% 10,941,600 1.38%
TOTAL: 34,767,335 4.39% 34,906,716 4.39%

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:
Details, including nature of the rights concerned and relevant percentages:

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant Purchase/sale Number of Price per unit
security securities
ADR Purchase 8,558 18.6318 USD
ADR Purchase 25,300 18.6004 USD
ADR Purchase 25,300 18.7296 USD
ADR Purchase 37,808 18.7400 USD
ADR Purchase 324,008 18.7205 USD
ADR Sale 8,558 18.6318 USD
ADR Sale 25,300 18.7296 USD
ADR Sale 25,300 18.6004 USD
ADR Sale 37,808 18.7400 USD
ADR Sale 286,200 18.7179 USD
Ordinary NPV Purchase 381 4,195.1233 JPY
Ordinary NPV Purchase 400 4,227.5000 JPY
Ordinary NPV Purchase 600 4,212.0000 JPY
Ordinary NPV Purchase 988 4,187.5628 JPY
Ordinary NPV Purchase 1,300 4,195.6153 JPY
Ordinary NPV Purchase 1,600 4,201.8250 JPY
Ordinary NPV Purchase 1,650 4,158.2959 JPY
Ordinary NPV Purchase 1,700 4,190.0000 JPY
Ordinary NPV Purchase 1,900 4,255.0000 JPY
Ordinary NPV Purchase 2,030 4,180.7975 JPY
Ordinary NPV Purchase 2,500 4,204.4000 JPY
Ordinary NPV Purchase 3,044 4,179.7644 JPY
Ordinary NPV Purchase 3,100 4,242.9354 JPY
Ordinary NPV Purchase 3,100 4,214.5000 JPY
Ordinary NPV Purchase 3,172 4,177.3417 JPY
Ordinary NPV Purchase 3,235 4,177.3326 JPY
Ordinary NPV Purchase 3,800 4,253.8947 JPY
Ordinary NPV Purchase 3,900 4,242.6666 JPY
Ordinary NPV Purchase 4,100 4,213.3414 JPY
Ordinary NPV Purchase 4,300 4,208.9162 JPY
Ordinary NPV Purchase 4,900 4,188.8734 JPY
Ordinary NPV Purchase 5,000 4,195.2200 JPY
Ordinary NPV Purchase 5,700 4,195.6491 JPY
Ordinary NPV Purchase 6,300 4,208.0936 JPY
Ordinary NPV Purchase 9,100 4,202.6043 JPY
Ordinary NPV Purchase 10,700 4,208.0373 JPY
Ordinary NPV Purchase 27,900 4,216.0000 JPY
Ordinary NPV Purchase 36,700 4,190.3773 JPY
Ordinary NPV Purchase 50,600 4,200.5158 JPY
Ordinary NPV Purchase 53,300 4,189.3921 JPY
Ordinary NPV Purchase 55,700 4,199.9138 JPY
Ordinary NPV Purchase 144,200 4,248.2926 JPY
Ordinary NPV Purchase 198,500 4,238.2614 JPY
Ordinary NPV Purchase 379,400 4,187.1470 JPY
Ordinary NPV Purchase 643,000 4,196.1883 JPY
Ordinary NPV Purchase 687,800 4,195.9816 JPY
Ordinary NPV Sale 200 4,159.0000 JPY
Ordinary NPV Sale 600 4,212.0000 JPY
Ordinary NPV Sale 600 4,217.3333 JPY
Ordinary NPV Sale 1,500 4,201.4666 JPY
Ordinary NPV Sale 1,500 4,124.0000 JPY
Ordinary NPV Sale 2,500 4,204.4000 JPY
Ordinary NPV Sale 3,100 4,214.5000 JPY
Ordinary NPV Sale 3,600 4,124.9166 JPY
Ordinary NPV Sale 3,900 4,205.1025 JPY
Ordinary NPV Sale 4,300 4,208.9162 JPY
Ordinary NPV Sale 4,500 4,210.6000 JPY
Ordinary NPV Sale 4,900 4,188.8734 JPY
Ordinary NPV Sale 5,000 4,195.2200 JPY
Ordinary NPV Sale 6,300 4,208.0936 JPY
Ordinary NPV Sale 7,000 4,195.6428 JPY
Ordinary NPV Sale 9,100 4,202.6043 JPY
Ordinary NPV Sale 10,000 4,240.6119 JPY
Ordinary NPV Sale 17,400 4,159.3678 JPY
Ordinary NPV Sale 17,400 4,190.6781 JPY
Ordinary NPV Sale 36,500 4,190.5493 JPY
Ordinary NPV Sale 38,100 4,135.6220 JPY
Ordinary NPV Sale 53,300 4,189.3921 JPY
Ordinary NPV Sale 55,700 4,199.1885 JPY
Ordinary NPV Sale 506,200 4,228.5029 JPY
Ordinary NPV Sale 643,000 4,196.1883 JPY
Ordinary NPV Sale 699,500 4,194.7107 JPY

(b) Cash-settled derivative transactions

Class of Product Nature of dealing Number of Price per
relevant description reference unit
security securities
Ordinary NPV SWAP Long 10,000 4,240.6118 JPY
Ordinary NPV SWAP Short 381 4,195.1234 JPY
Ordinary NPV SWAP Short 400 4,218.2500 JPY
Ordinary NPV SWAP Short 988 4,187.5642 JPY
Ordinary NPV CFD Short 1,000 4,124.4120 JPY
Ordinary NPV SWAP Short 1,600 4,201.8252 JPY
Ordinary NPV SWAP Short 1,650 4,158.2962 JPY
Ordinary NPV SWAP Short 2,030 4,180.7979 JPY
Ordinary NPV SWAP Short 3,044 4,179.7644 JPY
Ordinary NPV SWAP Short 3,172 4,177.3422 JPY
Ordinary NPV SWAP Short 3,235 4,177.3328 JPY
Ordinary NPV CFD Short 27,900 4,216.0000 JPY

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security Product description e.g. call option Writing, purchasing, selling, varying etc. Number of securities to which option relates Exercise price per unit Type

e.g. American, European etc.

Expiry date Option money paid/ received per unit

(ii) Exercise

Class of relevant security Product description

e.g. call option

Exercising/ exercised against Number of securities Exercise price per unit

(d) Other dealings (including subscribing for new securities)

Class of relevant security Nature of dealing

e.g. subscription, conversion

Details Price per unit (if applicable)

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

None

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

None

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 10 Dec 2018
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

SUPPLEMENTAL FORM 8 (OPEN POSITIONS)

DETAILS OF OPEN STOCK-SETTLED DERIVATIVE (INCLUDING OPTION) POSITIONS, AGREEMENTS TO PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the “Code”)

1. KEY INFORMATION

Identity of the person whose positions/dealings Barclays PLC.
are being disclosed:
Name of offeror/offeree in relation to whose TAKEDA PHARMACEUTICAL CO LTD
relevant securities this from relates:

2. STOCK-SETTLED DERIVATIVES (INCLUDING OPTIONS)

Class Product Writing, Number Exercise Type Expiry
of description purchasing, of price date
relevant selling, securities per unit
security varying etc to which
option
relates
Ordinary NPV Call Options Purchased 39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Purchased 40,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -460,000 6182.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Written -104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Call Options Written -78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Call Options Written -75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Call Options Written -70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Purchased -39,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 70,000 4598.0000 European 14 Jun 2019
Ordinary NPV Put Options Written 75,900 4286.5200 European 6 Sep 2019
Ordinary NPV Put Options Written 78,000 5781.0000 European 14 Dec 2018
Ordinary NPV Put Options Written 104,700 5065.8300 European 17 Apr 2019
Ordinary NPV Put Options Written 114,000 4750.0200 European 14 May 2019
Ordinary NPV Call Options Purchased 10,000,000 4562.0355 European 4 Dec 2018
Ordinary NPV Call Options Written -10,000,000 4562.0355 European 4 Dec 2018
Ordinary NPV Put Options Purchased -10,000,000 4562.0355 European 4 Dec 2018
Ordinary NPV Put Options Written 10,000,000 4562.0355 European 4 Dec 2018

3. AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

It is not necessary to provide details on a Supplemental Form (Open Positions) with regard to cash-settled derivatives.

The currency of all prices and other monetary amounts should be stated.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20181210005235/en/

Copyright Business Wire 2018

Date   Source Headline
10th May 20243:03 pmRNSForm 8.3 - Tyman plc
10th May 20243:03 pmRNSForm 8.3 - Virgin Money UK plc
10th May 20242:55 pmRNSForm 8.3 - Spirent Communications plc
10th May 20242:54 pmRNSForm 8.3 - UK Commercial Property REIT Limited
10th May 20242:51 pmRNSForm 8.3 - Tritax Big Box REIT plc
10th May 20242:33 pmRNSForm 8.3 - Quanex Building Products Corporation
10th May 20242:32 pmRNSForm 8.3 - Network International Holdings plc
10th May 20242:30 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited Amend
10th May 20242:27 pmRNSForm 8.3 - Mattioli Woods plc
10th May 20242:26 pmRNSForm 8.3 - Lok’n Store Group plc
10th May 20242:26 pmRNSForm 8.3 - Wood Group (John) plc
10th May 20242:25 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
10th May 20242:24 pmRNSForm 8.3 - International Paper Company
10th May 20242:23 pmRNSForm 8.3 - Smith (DS) plc
10th May 202411:29 amRNSForm 38.5(b)-Irish Residential Properties REIT plc
10th May 202411:26 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
10th May 202411:16 amRNSForm 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd
10th May 202411:11 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
10th May 202411:11 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
10th May 202411:08 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
10th May 202411:07 amRNSForm 8.5 (EPT/NON-RI) - BHP Group Limited
10th May 202411:03 amRNSForm 8.5 (EPT/NON-RI) - Anglo American plc
10th May 20247:30 amRNSTransaction in Own Shares
9th May 20245:30 pmRNSBoard Committee Change
9th May 20242:30 pmRNSResult of AGM
9th May 20241:37 pmRNSForm 8.3 - Virgin Money UK plc
9th May 20241:36 pmRNSForm 8.3 - UK Commercial Property REIT Limited
9th May 20241:35 pmRNSForm 8.3 - Tritax Big Box REIT plc
9th May 20241:34 pmRNSForm 8.3 - Spirent Communications plc
9th May 20241:33 pmRNSForm 8.3 - Tyman plc
9th May 20241:33 pmRNSForm 8.3 - Quanex Building Products Corporation
9th May 20241:32 pmRNSForm 8.3 - Network International Holdings plc
9th May 20241:29 pmRNSForm 8.3 - Mattioli Woods plc
9th May 20241:29 pmRNSForm 8.3 - Lok’n Store Group plc
9th May 20241:28 pmRNSForm 8.3 - Wood Group (John) plc
9th May 20241:20 pmRNSForm 8.3 - Hipgnosis Songs Fund Limited
9th May 20241:17 pmRNSForm 8.3 - International Paper Company
9th May 20241:16 pmRNSForm 8.3 - Smith (DS) plc
9th May 202412:30 pmRNSAGM Statement
9th May 202411:51 amRNSForm 8.5(EPT/NON-RI)-International Distribut Serv
9th May 202411:50 amRNSForm 38.5(b) - IRISH RESIDENTIAL PROPER REIT PLC
9th May 202411:50 amRNSForm 8.5 (EPT/NON-RI)-Balanced Commercial Prop Tru
9th May 202411:49 amRNSForm 8.5(EPT/NON-RI)-GCP Asset Backed Income F Ltd
9th May 202411:49 amRNSForm 8.5 (EPT/NON-RI) - Redrow plc
9th May 202411:48 amRNSForm 8.5 (EPT/NON-RI) - BHP Group Limited
9th May 202411:47 amRNSForm 8.5 (EPT/NON-RI) - Barratt Developments plc
9th May 202411:45 amRNSForm 8.5 (EPT/NON-RI) - Anglo American plc
9th May 20247:30 amRNSTransaction in Own Shares
8th May 20246:25 pmRNSPublication of Final Terms
8th May 20244:35 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.